The invention discloses the use of a protein with an amino acid sequence according to SEQ.ID.NO.1 or a naturally occurring fragment or variant thereof for identifying infections with S. aureus in a human sample.
More specifically, IgE molecules specific for SEQ.ID.NO.1 are detected in the sample of the patient. Many atopic dermatitis patients have IgE specific for SEQ.ID.NO.1.
